Shao Wei-Li sold $88K of OMDA
Shao Wei-Li (President) sold 4,036 shares of Omada Health, Inc. (OMDA) at an average of $21.85 ($21.78–$22.53) across 2 trades on 2026-09-10 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is small and pre‑arranged, offering little new insight for traders.
Market read
Limited relevance; the filing is routine and unlikely to affect trading decisions.
What to watch
The 10b5‑1 plan may mask timing decisions; however, the modest size limits significance.
Background
SEC Form 4 filing discloses insider transactions; required for public companies.
Ticker impact
President Shao Wei‑Li sold 4,036 shares for $88,206 via a 10b5‑1 plan, reducing his stake to 295,313 shares.
No material impact on OMDA share price.
The sale amount is small relative to market cap and follows a pre‑arranged plan, indicating no new negative information.
Market effects
None; Omada operates in digital health, a niche sector with limited spillover from this insider sale.
No regional effect; the transaction is company‑specific.
Minimal; the filing does not affect broader market sentiment.
Counterpoint
If the insider were off‑loading due to undisclosed concerns, the sell could foreshadow weakness.
Key entities
- CompanyOmada Health, Inc.
Digital health platform listed on Nasdaq under ticker OMDA.
- ExecutiveShao Wei‑Li
President of Omada Health, filing the insider sale.
